| Boy allergic to food lives on formula | | Posted Monday, March 12, 2007 2:53:53 PM by Blog57 Team | | To the untrained eye, nothing looks amiss with Nate LaDeur. The energetic and precocious Naperville 4-year-old is a whirl of motion on a recent weekday morning, practicing free throws from all angles in the home he shares with his mom, dad and two big brothers. But for Nate, breakfast never brings a bowl of cereal or a plate of eggs. The morning meal, like all of his snacks, and lunch and dinner, takes the form of a not-very-tasty, predigested prescription formula called EO28: Splash. Disguised with orange-pineapple flavoring and packaged in an orange, kid-friendly juice box, it's the only food Nate's body can tolerate. .... | |
| |
| | | Colon cancer drug finds new use in treating eye problem | | Posted Sunday, December 17, 2006 12:56:47 PM by Blog57 Team | | Good news to diabetics who are suffering from eye problems, especially with the retinas of their eyes: A drug approved for colon cancer treatment, called Avastin, is now here to treat advanced stages of diabetic eye disease.Marianas Eye Institute chief executive officer Russ Quinn said that resident physician Dr. David Khorram, the only ophthalmologist on the island, has joined the ranks of progressive retina specialists and ophthalmologists around the world who are using the cancer drug to treat eye diseases."We have seen a huge benefit to many of the CNMI's diabetic patients from this drug," said Dr. Khorram.He said that when the drug was approved by the FDA for use in colon cancer, ophthalmologists began using Avastin to treat severe forms of "proliferative" diabetic eye disease. Khorram said one of the most devastating problems with diabetic eye disease is the growth of new abnormal blood vessels inside the eye.... | |
| |
| | | Free eye screenings offered | | Posted Saturday, November 11, 2006 11:02:44 AM by Blog57 Team | | Free screening for two kinds of eye diseases will be provided by the Marshfield Clinic from 9 a.m. to 4 p.m. Wednesday, Nov. 29, at the Greenwood Center, 102 W. Cannery St., Greenwood. Both diseases, diabetic retinopathy and macular degeneration, can have devastating affects if left untreated. The screenings are open to the public, but advance registration is required. For more information, call the Greenwood Clinic at 715-267-6600 or 1-800-782-8581, ext. 9-3694. .... | |
| |
| | | (AFX UK Focus) 2006-11-02 21:27 GMT: ISTA 3Q loss widens on higher expenses | | Posted Saturday, November 04, 2006 7:05:02 AM by Blog57 Team | | IRVINE, Calif. (AFX) - ISTA Pharmaceuticals, a developer of treatments for eye conditions and diseases, said Thursday its third-quarter loss widened as expenses, including licensing agreement payments, increased. The company lost $11.5 million, or 44 cents per share, compared with a loss of $9.1 million, or 35 cents per share, a year ago. Analysts polled by Thomson Financial expected a loss of 36 cents per share. Revenue more than doubled to $8.7 million from $3.6 million. Analysts expected revenue of $9.5 million. The boost came largely from sales of ocular inflammation drug Xibrom, which accounted for $5.6 million of revenue, compared to $1.9 million a year ago. Expenses jumped 41 percent to $17.2 million from $12.1 million. Research and development costs, including a $2 million licensing payment, nearly doubled to $8 million.... | |
| |
| | | COMMUNITY BRIEFS | | Posted Saturday, October 28, 2006 6:58:16 AM by Blog57 Team | | "Getting through the Holidays" is the theme of a gathering for those who could use help facing Thanksgiving, Christmas, Chanukah, New Years, anniversaries, birthdays and other holidays after the loss of someone dear to them. Sponsored by Hospice of Ukiah and open to the public without charge, this 2 hour meeting will convene on Nov. 6 from 7 to 9 p.m. at the Hospice of Ukiah office, 650 S. Dora, Suite 101. People are welcome to come to this evening as a one-time event or as the first session in a series of eight weekly meetings of a new Grief Recovery Support Group starting Nov. 6 and running through Jan 1. The group will meet on successive Monday evenings from 7 to 9 p.m. at the Hospice of Ukiah office at 650 S. Dora Street., Suite 101. There is no charge for participation in the group.... | |
| |
| | | West Coast Editor | | Posted Saturday, October 21, 2006 6:54:24 AM by Blog57 Team | | Bayer Healthcare is paying Regeneron Pharmaceuticals Inc. up to $320 million - including $75 million up front - in a deal centered on VEFG Trap for diseases of the eye, and expects to start a Phase III trial in the first half of next year comparing the drug to Lucentis against age-related macular degeneration. Regeneron's stock (NASDAQ:REGN) closed Thursday at $18.78, up 90 cents. Len Schleifer, president and CEO of Tarrytown, N.Y.-based Regeneron, said his firm's product "binds [VEGF] fast and binds it tight," adding "this affinity, if you will, may be 50 to 100 times better than Lucentis," the AMD therapy from Genentech Inc., which reaped $153 million, far more than expected, during its first full quarter on the market. (See BioWorld Today, Oct. 12, 2006.) Leverkusen, Germany-based Bayer and Regeneron will jointly commercialize VEGF Trap-Eye (now in Phase I and Phase II trials) outside the U.S and split profits from ex-U.S.... | |
| |
| | | Sight Test and Glasses Could Dramatically Improve the Lives of 150 ... | | Posted Sunday, October 15, 2006 12:53:16 PM by Blog57 Team | | GENEVA, Oct. 12 /Xinhua-PRNewswire/ -- A simple sight test and eyeglasses or contact lenses could make a dramatic difference to the lives of more than 150 million people who are suffering from poor vision. Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment. (Logo: http://www.newscom.com/cgi-bin/prnh/20040610/CNTH001LOGO ) To mark World Sight Day, 12 October 2006, the World Health Organization (WHO) has released new global estimates which, for the first time, reveal that 153 million people around the world have uncorrected refractive errors (more commonly known as near-sightedness, far-sightedness and astigmatism). Refractive errors can be easily diagnosed, measured and corrected with eyeglasses or contact lenses, yet millions of people in low and middle income countries do not have access to these basic services.... | |
| |
| | | Eye Con at Jabalpur | | Posted Saturday, October 14, 2006 2:54:19 PM by Blog57 Team | | Jabalpur, Oct 11: The Eye Con-2006, a three-day 30th annual conference of Madhya Pradesh Opthalmic Society will be held in the city from October 13. The Jabalpur Chapter of Ophthalmic Society is hosting this annual conference. As many as 250 ophthalmologists from all over the country are expected to take part in this conference. Chairman of the Organising Committee Dr SC Batalia Secretary Dr Ravin N Das, Joint Secretary Dr Ravi Agarwal informed about the same to the media persons. Major attraction of `Eye CO-2006 would be discussion on advanced treatment of cataract through hacoemuilsification method, ocular surface diseases and others. During the conference, two courses on eye ailments caused due to diabetes , stichless micro cataract operation, would be held . Along with this a free paper session, scientific poster exhibition, video session on eye ailments, has been planned by the organisers.... | |
| |
| | | Researchers Uncover Critical Player In Cell Communication | | Posted Saturday, October 07, 2006 10:56:23 PM by Blog57 Team | | Johns Hopkins researchers have teased out the function of a protein implicated in Williams-Beuren syndrome, a rare cognitive disorder associated with overly social behavior and lack of spatial awareness. Called TFII-I, or TF "two eye," the protein long known to help control a cell's genes also controls how much calcium a cell takes in, a function critical for all cells, including nerves in the brain. The study will be published this week in Science. .... | |
| |
| | | UI Teams Up With Cubs' Star, Celtics' Owner To Fight Eye Disease | | Posted Sunday, October 01, 2006 6:57:22 AM by Blog57 Team | | Chicago Cubs first baseman Derrek Lee today announced his partnership with Boston Celtics CEO and co-owner Wyc Grousbeck and the Carver Nonprofit Genetic Testing Laboratory at the University of Iowa Roy J. and Lucille A. Carver College of Medicine to combat Leber congenital amaurosis (LCA), an important cause of genetic blindness in children. .... | |
| |
| |
|
|
